Published in Mol Carcinog on December 01, 1996
Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc Natl Acad Sci U S A (1997) 1.69
Synergistic modulation of cyclobutane pyrimidine dimer photoproduct formation and deamination at a TmCG site over a full helical DNA turn in a nucleosome core particle. Nucleic Acids Res (2014) 0.83
Characterisation of the p53-mediated cellular responses evoked in primary mouse cells following exposure to ultraviolet radiation. PLoS One (2013) 0.80
In vivo DNase I-mediated footprinting analysis along the human bradykinin B1 receptor (BDKRB1) gene promoter: evidence for cell-specific regulation. Biochem J (2005) 0.77
Rapid Deamination of Cyclobutane Pyrimidine Dimer Photoproducts at TCG Sites in a Translationally and Rotationally Positioned Nucleosome in Vivo. J Biol Chem (2015) 0.77
The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J (1998) 6.08
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet (2000) 5.50
Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science (1996) 5.17
p14ARF links the tumour suppressors RB and p53. Nature (1998) 4.78
X-chromosome inactivation and cell memory. Trends Genet (1992) 3.76
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.25
A population of fast radio bursts at cosmological distances. Science (2013) 3.03
Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis (2001) 2.66
Maternal-specific footprints at putative CTCF sites in the H19 imprinting control region give evidence for insulator function. Curr Biol (2000) 2.46
Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J Natl Cancer Inst (2000) 2.27
Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J (1995) 2.26
Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science (1994) 2.21
Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res (2001) 2.18
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J (1996) 2.12
Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol Cell Biol (1996) 1.99
In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol Cell Biol (1995) 1.93
Cyclobutane pyrimidine dimers are responsible for the vast majority of mutations induced by UVB irradiation in mammalian cells. J Biol Chem (2001) 1.80
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med (1986) 1.79
The tumor suppressor RASSF1A in human carcinogenesis: an update. Histol Histopathol (2005) 1.76
Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc Natl Acad Sci U S A (1997) 1.69
Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA (1998) 1.67
Mdm2 binds p73 alpha without targeting degradation. Oncogene (1999) 1.62
Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev (1997) 1.59
Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene (1995) 1.57
Two individuals with elliptocytic red cells apparently lack three minor erythrocyte membrane sialoglycoproteins. Biochem J (1984) 1.56
Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells. J Clin Endocrinol Metab (2001) 1.54
Intraoperative mannitol does not prevent renal failure in orthotopic liver transplantation. Crit Care Resusc (2001) 1.40
Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers. Oncogene (1998) 1.38
Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. Histol Histopathol (2003) 1.38
E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell (1999) 1.34
EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. J Clin Oncol (1993) 1.34
Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene (1995) 1.34
Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. Biochem Biophys Res Commun (2001) 1.33
The DNA damage spectrum produced by simulated sunlight. J Mol Biol (2000) 1.31
Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen. J Clin Invest (1995) 1.30
In vivo protein-DNA interactions at the c-jun promoter: preformed complexes mediate the UV response. Mol Cell Biol (1993) 1.29
Accumulation of p16INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status. Oncogene (1997) 1.27
DNA repair domains within a human gene: selective repair of sequences near the transcription initiation site. EMBO J (1996) 1.25
Ligation-mediated PCR improves the sensitivity of methylation analysis by restriction enzymes and detection of specific DNA strand breaks. Nucleic Acids Res (1990) 1.24
Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry (2009) 1.22
Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs. J Clin Invest (2000) 1.22
Isolation and characterization of DNA cytosine 5-methyltransferase from human placenta. Biochim Biophys Acta (1983) 1.20
Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas. Int J Cancer (2001) 1.20
Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases. Cancer Res (1997) 1.19
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. J Clin Oncol (1994) 1.18
Extension product capture improves genomic sequencing and DNase I footprinting by ligation-mediated PCR. Nucleic Acids Res (1992) 1.17
The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene (2001) 1.17
The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer. Oncogene (1993) 1.15
Cyclobutane pyrimidine dimers form preferentially at the major p53 mutational hotspot in UVB-induced mouse skin tumors. Carcinogenesis (2000) 1.15
Mapping of UV photoproducts within ras proto-oncogenes in UV-irradiated cells: correlation with mutations in human skin cancer. Oncogene (1992) 1.11
UV light as a footprinting agent: modulation of UV-induced DNA damage by transcription factors bound at the promoters of three human genes. J Mol Biol (1995) 1.11
8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res Treat (1986) 1.11
Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol (1997) 1.10
Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines. Genes Chromosomes Cancer (2000) 1.09
Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: characterization of additional microgranular variants. Am J Hematol (1997) 1.09
UV damage and repair mechanisms in mammalian cells. Bioessays (1996) 1.08
PCR-aided DNaseI footprinting of single copy gene sequences in permeabilized cells. Nucleic Acids Res (1990) 1.08
Primary care and population factors associated with NHS Health Check coverage: a national cross-sectional study. J Public Health (Oxf) (2013) 1.08
Autocrine and paracrine growth regulation of human breast cancer. J Steroid Biochem (1986) 1.06
Perturbation of the p53 response by human papillomavirus type 16 E7. J Virol (1997) 1.06
Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228. Cancer Res (2001) 1.05
Inhibition of transcription factor binding by ultraviolet-induced pyrimidine dimers. Biochemistry (1996) 1.05
Constitutive protection of E2F recognition sequences in the human thymidine kinase promoter during cell cycle progression. J Biol Chem (1997) 1.03
Similarities in sunlight-induced mutational spectra of CpG-methylated transgenes and the p53 gene in skin cancer point to an important role of 5-methylcytosine residues in solar UV mutagenesis. J Mol Biol (2001) 1.01
A children's acute respiratory illness scale (CARIFS) predicted functional severity and family burden. J Clin Epidemiol (2004) 1.00
Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression. Proc Natl Acad Sci U S A (2000) 1.00
Frequent epigenetic inactivation of cystatin M in breast carcinoma. Oncogene (2006) 0.99
Sequence-specific and domain-specific DNA repair in xeroderma pigmentosum and Cockayne syndrome cells. J Biol Chem (1997) 0.99
Sequence and time-dependent deamination of cytosine bases in UVB-induced cyclobutane pyrimidine dimers in vivo. J Mol Biol (1998) 0.98
Does short-term antiepileptic drug treatment in children result in cognitive or behavioral changes? Epilepsia (1998) 0.98
Characterization of novel parent-specific epigenetic modifications upstream of the imprinted mouse H19 gene. Mol Cell Biol (1998) 0.98
In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiation. Oncogene (1997) 0.98
Optimal insulin delivery in adolescents with diabetes: impact of intensive treatment on psychosocial adjustment. Diabetes Care (1984) 0.98
Growth regulation of human breast carcinoma occurs through regulated growth factor secretion. J Cell Biochem (1987) 0.96
Lack of gene- and strand-specific DNA repair in RNA polymerase III-transcribed human tRNA genes. Mol Cell Biol (1997) 0.95
Cell cycle-independent removal of UV-induced pyrimidine dimers from the promoter and the transcription initiation domain of the human CDC2 gene. Nucleic Acids Res (2000) 0.95
Involvement of 5-methylcytosine in sunlight-induced mutagenesis. J Mol Biol (1999) 0.95
Cerebrovascular arteriopathy (arteriosclerosis) and ischemic childhood stroke. Stroke (1982) 0.94
The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells. Oncogene (2012) 0.94
DNA methyltransferase polypeptides in mouse and human cells. Biochim Biophys Acta (1986) 0.94
Processing of UV damage in vitro by FEN-1 proteins as part of an alternative DNA excision repair pathway. Biochemistry (1999) 0.92
Frequent promoter methylation of tumor-related genes in sporadic and men2-associated pheochromocytomas. Exp Clin Endocrinol Diabetes (2005) 0.92
Candida albicans GRX2, encoding a putative glutaredoxin, is required for virulence in a murine model. Genet Mol Res (2007) 0.91
Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems. Mutat Res (1999) 0.91
Phase I study of infusional paclitaxel in combination with the P-glycoprotein antagonist PSC 833. J Clin Oncol (2001) 0.91
UV-induced DNA damage and mutations in Hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin. Cancer Res (2001) 0.91
The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts. Oncogene (1998) 0.91
In vivo structure of two divergent promoters at the human PCNA locus. Synthesis of antisense RNA and S phase-dependent binding of E2F complexes in intron 1. J Biol Chem (1999) 0.91
RASSF1A interacts with and activates the mitotic kinase Aurora-A. Oncogene (2008) 0.90
Loss of Rassf1a enhances p53-mediated tumor predisposition and accelerates progression to aneuploidy. Oncogene (2010) 0.90
Preferential binding of DNA methyltransferase and increased de novo methylation of deoxyinosine containing DNA. FEBS Lett (1986) 0.89
In vivo protein-DNA interactions at the c-jun promoter in quiescent and serum-stimulated fibroblasts. J Cell Biochem (1995) 0.89
Effect of an education programme on the utilization of a medical emergency team in a teaching hospital. Intern Med J (2006) 0.89
Purification and characterization of mammalian DNA methyltransferases by use of monoclonal antibodies. J Biol Chem (1985) 0.88
Functional characterization of the Candida albicans MNT1 mannosyltransferase expressed heterologously in Pichia pastoris. J Biol Chem (2000) 0.88
Candida cell wall mannosylation: importance in host-fungus interaction and potential as a target for the development of antifungal drugs. Biochem Soc Trans (1999) 0.88
Self-rating of pain in nonulcer dyspepsia. A methodological study comparing a new fixed-point scale and the visual analogue scale. J Clin Gastroenterol (1987) 0.88